First add-in therapy for MS - SIZOMUS
SIZOMUS is investigating the first proper adjunct (add-in) drug for MS. It is as well as your DMT, not instead of. It isn't a new compound but it is repurposing an existing drug with a well-established safety profile so I don't feel like a guinea pig for an unknown drug.
https://youtube.com/shorts/9XqE28Fz9sY